Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.
The item "Retained-Earnings" stands at 0.7422 Trillion Japanese Yens as of 06/30/2025.
As of the end of Astellas Pharma Inc.'s first quarter, the item "Retained Earnings" stands at 0.7422 Trillion JPY. This represents an increase of 0.17 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.30 percent compared to the value the year prior.
The 1 year change in percent is -5.30.
The 3 year change in percent is -19.76.
The 5 year change in percent is -19.22.
The 10 year change in percent is -14.32.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Retained Earnings | 905,699,262,464.00 |
![]() | Johnson & Johnson - Retained Earnings | 486,508,953,600.00 |
![]() | AbbVie Inc - Retained Earnings | 399,570,305,024.00 |
![]() | Roche Holding AG - Retained Earnings | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Retained Earnings | 280,205,508,085.11 |